Numerous blood pressure drugs are now involved in the recall that began in late July over a suspected cancer-causing compound.
The recall of blood pressure medications has now reached products coming from overseas.
On Friday, the Japanese subsidiary of Pfizer Inc. announced it was recalling a drug for high blood pressure due to a cancer-causing substance found in the medicatiion’s active ingredient valsartan.
The company told Reuters that more than 763,000 tablets of Amvalo manufactured between April and July in Mylan Laboratories Limited in India will be removed from store shelves.
Company officials said there have been no reports of any damage to anyone’s health, but they’re still proceeding with the recall out of caution.
It’s similar to the message that has been delivered the past six months from other companies that distribute blood pressure medications.